Telix Pharmaceuticals (TLX) Current Taxes (2023 - 2025)

Telix Pharmaceuticals (TLX) has 3 years of Current Taxes data on file, last reported at $30.7 million in Q4 2025.

• Current Taxes for Q4 2025 came in at $30.7 million, down 3.23% year-over-year; the trailing twelve-month figure through Dec 2025 was $30.7 million (down 3.23% YoY), and the FY2025 annual result was $30.7 million, up 2.18% from the prior year.
• Current Taxes eased to $30.7 million in Q4 2025 per TLX's latest filing, from $31.8 million in the prior quarter.
• Over five years, Current Taxes peaked at $31.8 million in Q4 2024 and troughed at $12.5 million in Q4 2023.
• A 3-year average of $25.0 million and a median of $30.7 million in 2025 frame the typical range for Current Taxes.
• The sharpest annual moves came in 2024 and 2025: Current Taxes surged 154.64% in 2024, then retreated 3.23% in 2025.
• A 3-year view of Current Taxes shows it stood at $12.5 million in 2023, then surged by 154.64% to $31.8 million in 2024, then decreased by 3.23% to $30.7 million in 2025.
• Business Quant data shows TLX's Current Taxes at $30.7 million in Q4 2025, $31.8 million in Q4 2024, and $12.5 million in Q4 2023.